Short synthetic endostatin peptides inhibit endothelial migration in vitro and endometriosis in a mouse model

Fertility and Sterility

Volumn 85, Issue 1, 2006, Pages 71-77

  Becker, Christian M ^a,b,c   Sampson, David A ^a   Short, Sarah M ^a   Javaherian, Kashi ^a   Folkman, Judah ^a   D'Amato, Robert J ^a,d  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Angiogenesis inhibitors; Animal model; Endometriosis; Endostatin

Indexed keywords

ENDOSTATIN; MURINE ENDOSTATIN PEPTIDE 1; MURINE ENDOSTATIN PEPTIDE 6; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; VASCULOTROPIN;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL GROWTH; CELL MIGRATION; CONTROLLED STUDY; CORPUS LUTEUM; ENDOMETRIOSIS; ENDOTHELIUM CELL; ESTRUS CYCLE; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MIGRATION INHIBITION; MOUSE; NONHUMAN; OVULATION; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANGIOGENESIS INHIBITORS; ANIMALS; CELL MOVEMENT; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOMETRIOSIS; ENDOSTATINS; ENDOTHELIAL CELLS; ESTROUS CYCLE; FEMALE; HUMANS; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; OVULATION; PEPTIDE FRAGMENTS;

EID: 30344431813     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2005.07.1290     Document Type: Article

References (43)

1. D.W. Cramer, S.A. Missmer The epidemiology of endometriosis Ann NY Acad Sci 955 2002 11 22
2. L.C. Giudice, L.C. Kao Endometriosis Lancet 364 2004 1789 1799
3. D.L. Olive, E.A. Pritts Treatment of endometriosis N Engl J Med 345 2001 266 275
4. J. Folkman Angiogenesis in cancer, vascular, rheumatoid and other disease Nat Med 1 1995 27 31
5. D.L. Healy, P.A. Rogers, L. Hii, M. Wingfield Angiogenesis a new theory for endometriosis Hum Reprod Update 4 1998 736 740
6. R.N. Taylor, D.I. Lebovic, M.D. Mueller Angiogenic factorss in endometriosis Ann NY Acad Sci 955 2002 89 100
7. R.N. Taylor, M.D. Mueller Anti-angiogenic treatment of endometriosis biochemical aspects Gynecol Obstet Invest 57 2004 54 56
8. M.S. O'Reilly, T. Boehm, Y. Shing, N. Fukai, G. Vasios, W.S. Lane Endostatin an endogenous inhibitor of angiogenesis and tumor growth Cell 88 1997 277 285
9. C.M. Becker, D.A. Sampson, M.A. Rupnick, R.M. Rohan, J.A. Efstathiou, S.M. Short Endostatin inhibits the growth of endometriotic lesions but does not affect fertility Fertil Steril 84 Suppl 2 2005 1144 1155
10. A.W. Nap, A.W. Griffioen, G.A. Dunselman, J.C. Bouma-Ter Steege, V.L. Thijssen, J.L. Evers Antiangiogenesis therapy for endometriosis J Clin Endocrinol Metab 89 2004 1089 1095
11. T. Boehm, M.S. O'Reilly, K. Keough, J. Shiloach, R. Shapiro, J. Folkman Zinc-binding of endostatin is essential for its antiangiogenic activity Biochem Biophys Res Commun 252 1998 190 194
12. R.M. Tijn Tham Sjin, R. Satchi-Fainaro, A.E. Birsner, V.M. Ramanujam, J. Folkman, K. Javaherian A 27 amino acid synthetic peptide corresponding to the N-terminal zinc binding domain of endostatin is responsible for its anti-tumor activity Cancer Res 65 2005 3656 3663
13. A.M. Cummings, J.L. Metcalf Induction of endometriosis in mice a new model sensitive to estrogen Reprod Toxicol 9 1995 233 238
14. M.W. Vernon, E.A. Wilson Studies on the surgical induction of endometriosis in the rat Fertil Steril 44 1985 684 694
15. J. Donnez, C. Pirard, M. Smets, P. Jadoul, J. Squifflet Pre- and post-surgical management of endometriosis Semin Reprod Med 21 2003 235 242
16. C.M. Becker, J. Bartley, S. Mechsner, A.D. Ebert Angiogenesis and endometriosis Zentralbl Gynakol 126 2004 252 258
17. J. McLaren Vascular endothelial growth factor and endometriotic angiogenesis Hum Reprod Update 6 2000 45 55
18. A. Arici, S.I. Tazuke, E. Attar, H.J. Kliman, D.L. Olive Interleukin-8 concentration in peritoneal fluid of patients with endometriosis and modulation of interleukin-8 expression in human mesothelial cells Mol Hum Reprod 2 1996 40 45
19. J.C. Huang, C. Papasakelariou, M.Y. Dawood Epidermal growth factor and basic fibroblast growth factor in peritoneal fluid of women with endometriosis Fertil Steril 65 1996 931 934
20. J. McLaren, A. Prentice, D.S. Charnock-Jones, S.K. Smith Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis Hum Reprod 11 1996 220 223
21. D.J. Oosterlynck, C. Meuleman, M. Waer, P.R. Koninckx Transforming growth factor-beta activity is increased in peritoneal fluid from women with endometriosis Obstet Gynecol 83 1994 287 292
22. Y. Osuga, O. Tsutsumi, R. Okagaki, Y. Takai, A. Fujimoto, A. Suenaga Hepatocyte growth factor concentrations are elevated in peritoneal fluid of women with endometriosis Hum Reprod 14 1999 1611 1613
23. I.P. Ryan, J.F. Tseng, E.D. Schriock, O. Khorram, D.V. Landers, R.N. Taylor Interleukin-8 concentrations are elevated in peritoneal fluid of women with endometriosis Fertil Steril 63 1995 929 932
24. A.M. Steff, D. Gagne, M. Page, A. Rioux, P. Hugo, D. Gosselin Serum concentrations of insulin-like growth factor-1, soluble tumor necrosis factor receptor-1 and angiogenin in endometriosis patients Am J Reprod Immunol 51 2004 166 173
25. M. Ulukus, E. Cagnur Ulukus, Y. Seval, W. Zheng, A. Arici Expression of interleukin-8 receptors in endometriosis Hum Reprod 30 2005 343 348
26. D.L. Olive, S.R. Lindheim, E.A. Pritts New medical treatments for endometriosis Best Pract Res Clin Obstet Gynaecol 18 2004 319 328
27. C. Dabrosin, S. Gyorffy, P. Margetts, C. Ross, J. Gauldie Therapeutic effect of angiostatin gene transfer in a murine model of endometriosis Am J Pathol 161 2002 909 918
28. M.L. Hull, D.S. Charnock-Jones, C.L. Chan, K.L. Bruner-Tran, K.G. Osteen, B.D. Tom Antiangiogenic agents are effective inhibitors of endometriosis J Clin Endocrinol Metab 88 2003 2889 2899
29. J.M. Ingelmo, F. Quereda, P. Acien Intraperitoneal and subcutaneous treatment of experimental endometriosis with recombinant human interferon-alpha-2b in a murine model Fertil Steril 71 1999 907 911
30. E. Somigliana, P. Vigano, G. Rossi, S. Carinelli, M. Vignali, P. Panina-Bordignon Endometrial ability to implant in ectopic sites can be prevented by interleukin-12 in a murine model of endometriosis Hum Reprod 14 1999 2944 2950
31. E. Marshall Cancer therapy Setbacks for endostatin Science 295 2002 2198 2199
32. Y.H. Ding, K. Javaherian, K.M. Lo, R. Chopra, T. Boehm, J. Lanciotti Zinc-dependent dimers observed in crystals of human endostatin Proc Natl Acad Sci USA 95 1998 10443 10448
33. B.K. Sim, W.E. Fogler, X.H. Zhou, H. Liang, J.W. Madsen, K. Luu Zinc ligand-disrupted recombinant human Endostatin potent inhibition of tumor growth, safety and pharmacokinetic profile Angiogenesis 3 1999 41 51
34. N. Yamaguchi, B. Anand-Apte, M. Lee, T. Sasaki, N. Fukai, R. Shapiro Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding EMBO J 18 1999 4414 4423
35. D. Ingber, T. Fujita, S. Kishimoto, K. Sudo, T. Kanamaru, H. Brem Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth Nature 348 1990 555 557
36. N. Klauber, R.M. Rohan, E. Flynn, R.J. D'Amato Critical components of the female reproductive pathway are suppressed by the angiogenesis inhibitor AGM-1470 Nat Med 3 1997 443 446
37. J.P. Eder Jr, J.G. Supko, J.W. Clark, T.A. Puchalski, R. Garcia-Carbonero, D.P. Ryan Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily J Clin Oncol 20 2002 3772 3784
38. M.G. Cattaneo, S. Pola, P. Francescato, F. Chillemi, L.M. Vicentini Human endostatin-derived synthetic peptides possess potent antiangiogenic properties in vitro and in vivo Exp Cell Res 283 2003 230 236
39. F. Chillemi, P. Francescato, E. Ragg, M.G. Cattaneo, S. Pola, L. Vicentini Studies on the structure-activity relationship of endostatin synthesis of human endostatin peptides exhibiting potent antiangiogenic activities J Med Chem 46 2003 4165 4172
40. L. Morbidelli, S. Donnini, F. Chillemi, A. Giachetti, M. Ziche Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin Clin Cancer Res 9 2003 5358 5369
41. R.J. D'Amato, M.S. Loughnan, E. Flynn, J. Folkman Thalidomide is an inhibitor of angiogenesis Proc Natl Acad Sci USA 91 1994 4082 4085
42. W.G. McBride Thalidomide and congenital abnormalities Lancet 278 1961 1358
43. D.H.M. Woollam Thalidomide and the mouse Br Med J 5309 1962 920